CAPR stock

Capricor Therapeutics Inc (CAPR) financials · $1.62B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Capricor Therapeutics Inc (CAPR) $1.62B cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/A$22.3M
Operating Income-$108.1M-$42.6M
Net Income-$105.0M-$40.5M
EPS (Diluted)-$2.26-$1.15
Cached annual balance sheet
LineFY2025FY2024
Total Assets$355.9M$170.5M
Current Assets$322.9M$163.4M
Cash & Equivalents$287.8M$11.3M
PP&E$18.3M$5.56M
Total Liabilities$50.2M$25.0M
Current Liabilities$35.8M$21.0M
Shareholders' Equity$305.8M$145.5M
Retained Earnings-$304.9M-$199.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$69.8M-$40.0M
CapEx$2.90M$1.17M
Investing Cash Flow$97.5M-$116.2M
Financing Cash Flow$248.9M$152.8M
Free Cash Flow-$72.7M-$41.2M
These statements as JSON? API free 100/day

FAQ

What is CAPR P/E and revenue?

Capricor Therapeutics Inc (CAPR) $1.62B cap.

What is CAPR revenue?

CAPR income-statement cache has no revenue figure yet.

Is CAPR profitable?

Capricor Therapeutics Inc last cached net income is -$105.0M (FY2025).

What are CAPR total assets?

Capricor Therapeutics Inc last cached total assets are $355.9M (FY2025).

What is CAPR free cash flow?

Capricor Therapeutics Inc last cached free cash flow is -$72.7M (FY2025).

Not investment advice. Cached statements, not a live tape.